hBD-1 vs Omentin-1
Head-to-head comparison of hBD-1 (Human beta-defensin 1) and Omentin-1 (Omentin-1 (Intelectin-1, ITLN1)) — benefits, dosing, side effects, research data, and where to buy.
| Property | hBD-1 | Omentin-1 |
|---|---|---|
| Category | Dental & Oral | Diabetes & Metabolic |
| Full Name | Human beta-defensin 1 | Omentin-1 (Intelectin-1, ITLN1) |
| Molecular Weight | 4490 Da | ~35 kDa |
| Half-Life | minutes to hours | hours |
| Amino Acids | 36 | 313 |
| Typical Dose | 1-10 µg/mL in experimental studies | No approved human dose; research use only |
| Route | Topical/Intraoral | IV|SC |
| Purity | ≥98% | ≥98% |
| Studies Count | 85 | 82 |
| Research Status | Pre-clinical | Pre-clinical |
hBD-1 Benefits
- ✓oral innate immunity
- ✓broad antimicrobial activity
- ✓biofilm suppression
- ✓periodontal support
Omentin-1 Benefits
- ✓insulin sensitivity
- ✓glucose uptake
- ✓lipid handling
hBD-1 Dosing
topical peptide exposure|cell-culture or mucosal models|repeat low-dose application in research
Omentin-1 Dosing
not established|not established
hBD-1 Side Effects
- ⚠protease degradation
- ⚠local irritation at high dose
- ⚠limited stability in saliva
Omentin-1 Side Effects
- ⚠unknown
- ⚠immunogenicity risk
Research Overview
hBD-1
hBD-1 has been studied as part of the oral mucosal defense system and is linked to host resistance against dental pathogens. Research spans periodontitis, candidiasis, and epithelial barrier biology.
Omentin-1
Lower omentin-1 levels are often associated with obesity, insulin resistance, and metabolic syndrome. Research continues on its use as a biomarker and as a mechanistic lead for AMPK-linked metabolic interventions.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.